• No results found

Red blood cell alloimmunization after bone-allograft transplantationL. PRINZEN

N/A
N/A
Protected

Academic year: 2021

Share "Red blood cell alloimmunization after bone-allograft transplantationL. PRINZEN"

Copied!
1
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

139 Ned Tijdschr Klin Chem Labgeneesk 2013, vol. 38, no. 3

In this case report, we provide evidence for the pos- sibility of red blood cell alloimmunization after bone- allograft transplantation (1). A 13-year-old boy with spastic diplegia probably caused by hypoxic encepha- lopathy at birth, had to undergo two surgeries because of impending bilateral hip-luxation. The surgeries were scheduled 5 months apart; during both he re- ceived femoral bone allografts. He had no history of blood transfusion, also during these surgeries no blood products were administered. Prior to implantation, the bone-allografts, recovered from living donors and stored at -80 °C for at least 6 months, were washed in saline and antibiotics. The allograft used during the first surgery was approximately 75 g in weight and 7 mL in volume.

The patient had bloodgroup 0, with rhesus phenotype ccdee and K negative; initial screening was negative.

However, prior to the second surgery three RBC anti- bodies were identified: anti-D (2+ in LISS, 4+ in pa- painized cells), anti-E (1+ in LISS, 3/4+in papainized cells) and anti-C (2/3+ in LISS, 4+ in papainized cells).

DAT was negative. The only reasonable explanation for immunization was the first bone allograft. This was confirmed by the blood group and rhesus pheno- type of the first donor: bloodgroup 0, rhesus pheno- type CcDEe and K negative. Screening was repeated 6 weeks after the second hip surgery in order to confirm the first positive screening and was again positive for anti-D, anti-C and anti-E (similar reaction strengths).

Discussion

With this case report, we show that also transplanta- tion of nonvascularized tissue, such as a femoral bone allograft, may cause RBC alloimmunization. It is un- likely that intact RBCs or bone marrow stem cells are still present in the bone allograft. However, antigen- presenting remnants may still be confined inside the allograft. There is no literature available about RBC remnants in frozen bone allografts. However, a unit of fresh frozen plasma, containing fewer than 1 × 10

8

RBCs, is considered safe with respect to the risk of rhesus D immunization (2). This suggests that more

RBC remnants were present in the used bone allograft in this case.

Little is known about RBC alloimmunization after organ transplantation. Presumably, this is not very common in organ-transplant patients due to the use of immunosuppressants. However, this is uncommon in bone-transplant cases, which may explain why alloim- munization did occur. This would suggest that allo- immunization occurs more often after bone-allograft transplantation. To our knowledge only seven cases of RBC alloimmunization after bone allografting have been described in the literature (3-6), all females. All of them were already of childbearing age, although prior pregnancies were denied. On the other hand, a study of 144 patients with transplanted cancellous bone chips did not show alloimmunization (7). How- ever, the authors acknowledge that only small amounts of bone were transplanted.

Conclusion

We report here the first male patient who developed RBC alloantibodies after bone-allograft transplanta- tion, providing evidence that transplantation of non- vascular tissue such as a bone allograft can cause pri- mary RBC alloimmunization.

References

1. Prinzen L, Staal HM, Rouwette SJ, Beckers EA, ten Broeke RH, van Rhijn LW, et al. Triple red blood cell al- loantibody formation after bone-allograft transplantation.

Am J Transplant. 2013; 13: 229-231.

2. Vrielink H, van der Meer PF. Collection of white blood cell- reduced plasma by apheresis. Transfusion. 2004; 44: 917-923.

3. Cheek RF, Harmon, JV, Stowell CP. Red cell alloimmuniza- tion after a bone allograft. Transfusion. 1995; 35: 507-509.

4. Johnson CA, Brown BA, Lasky LC. Rh immunization caused by osseous allograft. N Engl J Med. 1985; 312: 121-122.

5. Jensen TT. Rhesus immunization after bone allografting.

A case report. Acta Orthop Scand. 1987; 58: 584.

6. Hill Z, Vacl J, Kalasova E, Calabkova M, Pintera J. Hae- molytic disease of new-born due to anti-D antibodies in a Du-positive mother. Vox Sang. 1974; 27: 92-94.

7. Stassen JG, van Dijk BA, van Horn JR, Kunst VA. No irreg- ular erythrocyte antibodies observed after bone allo grafts in 144 patients. Acta Orthop Scand. 1993; 64: 354-356.

Ned Tijdschr Klin Chem Labgeneesk 2013; 38: 139

Red blood cell alloimmunization after bone-allograft transplantation

L. PRINZEN

1

, H.M. STAAL

2

, S.J.M. ROUWETTE

1

, E.A.M. BECKERS

3

, R.H.M. ten BROEKE

2

, L.W. van RHIJN

2

and Y. M. C. HENSKENS

1

Central Diagnostic Laboratory, Maastricht University Medical Center

1

; Department of Orthopedics, Maas- tricht University Medical Center

2

; Department of Inter- nal Medicine, Subdivision Hematology, Maastricht Uni- versity Medical Center

3

E-mail: l.prinzen@mumc.nl

Referenties

GERELATEERDE DOCUMENTEN

Chapter 2 Rhesus hemolytic disease of the newborn: postnatal management, associated morbidity and long-term outcome. Semin Fetal Neonatal Med

During this study period several study projects on management, complications and outcome in hemolytic disease of the newborn (HDN) due to red cell alloimmunization were

In our center term neonates with RHDN are treated with transfusions of red blood cells when hemoglobin levels fall below 8.0 g/dL (5.0 mmol/L) or below 9.6 g/dL

We recorded the following obstetric and neonatal data: fetal hemoglobin (Hb) concentration and gestational age at first IUT, number of IUTs, gestational age at birth, birth weight,

Umbilical venous catheterization was required in this case because an ET was deemed necessary to reduce the elevated bilirubin levels and the risk of

(classified according to Bell’s criteria 20 ), proven sepsis (clinical and/or biochemical signs of infection with a positive blood culture), suspected sepsis (clinical

6,8-10 Data on the incidence and severity of cholestasis in neonates with red cell alloimmune hemolytic disease is scarce, and little is known about pathogenesis, risk

We recorded the following obstetric and neonatal data: type of red cell alloimmunization, number of IUTs, presence of fetal hydrops, fetal platelet count before each IUT, number of